價(jià)格 | ¥1138 | ¥1880 | ¥2900 |
包裝 | 50ul | 100ul | 200ul |
最小起訂量 | 50ul |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-31 |
中文名稱:Anti-PD-L1 antibody-程序性死亡配體1(CD274)抗體 | 英文名稱:PD-L1 |
品牌: 滬震生物 | 產(chǎn)地: 中國/上海 |
保存條件: -20°C | 純度規(guī)格: > 99% |
產(chǎn)品類別: 抗體 一抗 | |
抗體名: Programmed cell death 1 ligand 1; CD274; B7 H; B7 H1; B7 homolog 1; B7-H1; B7H; B7H1; CD 274; CD274 antigen; CD274 molecule; MGC142294; MGC142296; OTTHUMP00000021029; PD L1; PD1L1_HUMAN; PDCD1 ligand 1; PDCD1L1; PDCD1LG1; PDL 1; PDL1; Programmed death ligand 1; RGD1566211. | 靶點(diǎn): 詳見說明書 |
宿主: Rabbit | 適應(yīng)物種: 詳見說明書 |
克隆性: 詳見說明書 | 濃度: 1mg/ml |
應(yīng)用范圍: WB=1:500-2000 not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. | 標(biāo)識(shí)物: 詳見說明書 |
形態(tài): 液體 | 亞型: IgG |
免疫原: 詳見說明書 | 貨號(hào): Hz-R4941 |
用途范圍: 科研使用 | 規(guī)格: 50ul/100ul/200ul |
是否進(jìn)口: 否 | 是否單克隆: 詳見說明書 |
保質(zhì)期: 12個(gè)月 | 抗原來源: 詳見說明書 |
標(biāo)記物: 詳見說明書 | 產(chǎn)品用途: WB=1:500-2000 not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
Rabbit Anti-PD-L1 Polyclonal Antibody
DATASHEET
Host:Rabbit
Target Protein:PD-L1
IR:Immunogen Range:
Clonality:Polyclonal
Isotype:IgG
Entrez Gene:29126
Swiss Prot:Q9NZQ7
Source:KLH conjugated synthetic peptide derived from human B7-H1/PD-L1/CD274:
Purification:affinity purified by Protein A
Storage:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Background:This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]
Size:50ul
Concentration:1mg/ml
Applications:WB(1:500-2000)
Cross Reactive Species:Human
Mouse
Rat
Pig
Cow
Horse
Rabbit
僅供科研使用。不能用于人和動(dòng)物治療等其它臨床診斷用!
成立日期 | 2014-05-08 (11年) | 注冊資本 | 100萬元整 |
員工人數(shù) | 10-50人 | 年?duì)I業(yè)額 | ¥ 100萬以內(nèi) |
主營行業(yè) | 生化試劑,細(xì)胞培養(yǎng),蛋白組學(xué),分子生物學(xué),細(xì)胞生物學(xué) | 經(jīng)營模式 | 工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP2年
|
北京百普賽斯生物科技股份有限公司
|
2024-12-16 | |
詢價(jià) |
VIP3年
|
上海嘉定區(qū)澄瀏公路52號(hào)
|
2024-12-30 | |
詢價(jià) |
VIP4年
|
上海冠導(dǎo)生物工程有限公司
|
2025-01-02 |